Publications & Posters
Scholary publications
Spinal Muscular Atrophy
Apitegromab
April 2019
Human Molecular Genetics
Specific Inhibition of Myostatin Activation is Beneficial in Mouse Models of SMA Therapy
Immuno-Oncology
SRK-181
November 2018
The Society for Immunotherapy of Cancer (SITC) 33rd Annual Meeting
Defeating checkpoint resistance: Highly specific inhibition of latent TGFβ1 activation renders resistant solid tumors vulnerable to PD-1 blockade
Anemia
SRK-256
October 2018
12th International BMP Conference
RGMc-selective antibodies modulate iron homeostasis in vivo
March 2018
Gordon Research Conference
Discovery of an isoform-specific inhibitor of TGFβ1 activation using antibody display technology
Spinal Muscular Atrophy
Apitegromab
February 2018
Scientific Reports
Blocking extracellular activation of myostatin as a strategy for treating muscle wasting
Platform
January 2018
The Embo Journal
